FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186486251> ?p ?o ?g. }

• W3186486251 endingPage "80" @default.
• W3186486251 startingPage "75" @default.
• W3186486251 abstract "Data on the impact of chronic kidney disease (CKD) on clinical outcomes in chronic total occlusion (CTO) patients is scarce, and the optimal treatment strategy for this population is not well established. This study aims to compare differences in CTO management and long-term clinical outcomes, including all-cause and cardiac mortalities, according to baseline glomerular filtration rate (GFR).All patients with at least one CTO diagnosed in our center between 2010 and 2014 were included. Demographic and clinical data were registered. All-cause and cardiac mortalities were assessed during a median follow-up of 4.03 years (IQR 2.6-4.8). Clinical outcomes were compared between patients with CKD (GFR < 60 mL/min/1.73 m2) and without CKD (GFR ≥ 60 mL/min/1.73 m2).A total of 1248 patients (67.3 ± 10.9 years; 32% CKD) were identified. CKD patients were older and had a higher prevalence of hypertension, type 2 diabetes, peripheral arterial disease, and severe left ventricular dysfunction compared to patients with normal renal function (p < 0.05). Subjects with renal dysfunction were more often treated with MT alone, compared to patients without CKD (63% vs 45%; p < 0.001), who were more likely to undergo PCI or surgery. During follow-up, 386 patients [31%] died. CKD patients had a higher rate of all-cause and cardiac mortalities compared to patients without CKD (p < 0.001). The independent predictors for all-cause mortality were age, GFR < 60 mL/min/1.73 m2, Syntax Score I, and successful revascularization of the CTO (CABG or PCI-CTO). Among patients with CKD, advanced age, eGFR <30 mL/min/1.73 m2, and CTO successful revascularization were predictors of all-cause mortality.Patients with CKD were more often treated with MT alone. At long-term follow-up, revascularization of the CTO is associated with lower all-cause and cardiac mortalities in this population." @default.
• W3186486251 created "2021-08-02" @default.
• W3186486251 creator A5000384897 @default.
• W3186486251 creator A5006982633 @default.
• W3186486251 creator A5008861835 @default.
• W3186486251 creator A5009775466 @default.
• W3186486251 creator A5011188783 @default.
• W3186486251 creator A5027869241 @default.
• W3186486251 creator A5031865284 @default.
• W3186486251 creator A5038121885 @default.
• W3186486251 creator A5039028080 @default.
• W3186486251 creator A5041525351 @default.
• W3186486251 creator A5070035659 @default.
• W3186486251 creator A5078963282 @default.
• W3186486251 creator A5079151837 @default.
• W3186486251 creator A5085997159 @default.
• W3186486251 creator A5087459878 @default.
• W3186486251 date "2022-05-01" @default.
• W3186486251 modified "2023-10-18" @default.
• W3186486251 title "Impact of Chronic Kidney Disease in Chronic Total Occlusion Management and Clinical Outcomes" @default.
• W3186486251 cites W1999584733 @default.
• W3186486251 cites W2005129848 @default.
• W3186486251 cites W2025589168 @default.
• W3186486251 cites W2047755480 @default.
• W3186486251 cites W2066135665 @default.
• W3186486251 cites W2087150869 @default.
• W3186486251 cites W2113760558 @default.
• W3186486251 cites W2140717913 @default.
• W3186486251 cites W2154140731 @default.
• W3186486251 cites W219166538 @default.
• W3186486251 cites W2416351751 @default.
• W3186486251 cites W2506993085 @default.
• W3186486251 cites W2513245700 @default.
• W3186486251 cites W2613038145 @default.
• W3186486251 cites W2801132219 @default.
• W3186486251 cites W2891760925 @default.
• W3186486251 cites W2916496138 @default.
• W3186486251 cites W2918243825 @default.
• W3186486251 cites W2942265404 @default.
• W3186486251 cites W2947687368 @default.
• W3186486251 cites W2951997824 @default.
• W3186486251 cites W2974932310 @default.
• W3186486251 cites W3007096196 @default.
• W3186486251 cites W3013648138 @default.
• W3186486251 cites W3030495074 @default.
• W3186486251 cites W3032901983 @default.
• W3186486251 cites W3039707385 @default.
• W3186486251 cites W3094861847 @default.
• W3186486251 doi "https://doi.org/10.1016/j.carrev.2021.07.018" @default.
• W3186486251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34334336" @default.
• W3186486251 hasPublicationYear "2022" @default.
• W3186486251 type Work @default.
• W3186486251 sameAs 3186486251 @default.
• W3186486251 citedByCount "3" @default.
• W3186486251 countsByYear W31864862512022 @default.
• W3186486251 crossrefType "journal-article" @default.
• W3186486251 hasAuthorship W3186486251A5000384897 @default.
• W3186486251 hasAuthorship W3186486251A5006982633 @default.
• W3186486251 hasAuthorship W3186486251A5008861835 @default.
• W3186486251 hasAuthorship W3186486251A5009775466 @default.
• W3186486251 hasAuthorship W3186486251A5011188783 @default.
• W3186486251 hasAuthorship W3186486251A5027869241 @default.
• W3186486251 hasAuthorship W3186486251A5031865284 @default.
• W3186486251 hasAuthorship W3186486251A5038121885 @default.
• W3186486251 hasAuthorship W3186486251A5039028080 @default.
• W3186486251 hasAuthorship W3186486251A5041525351 @default.
• W3186486251 hasAuthorship W3186486251A5070035659 @default.
• W3186486251 hasAuthorship W3186486251A5078963282 @default.
• W3186486251 hasAuthorship W3186486251A5079151837 @default.
• W3186486251 hasAuthorship W3186486251A5085997159 @default.
• W3186486251 hasAuthorship W3186486251A5087459878 @default.
• W3186486251 hasConcept C126322002 @default.
• W3186486251 hasConcept C134018914 @default.
• W3186486251 hasConcept C159641895 @default.
• W3186486251 hasConcept C164705383 @default.
• W3186486251 hasConcept C2778653478 @default.
• W3186486251 hasConcept C2779464278 @default.
• W3186486251 hasConcept C2908647359 @default.
• W3186486251 hasConcept C45393284 @default.
• W3186486251 hasConcept C500558357 @default.
• W3186486251 hasConcept C555293320 @default.
• W3186486251 hasConcept C71924100 @default.
• W3186486251 hasConcept C99454951 @default.
• W3186486251 hasConceptScore W3186486251C126322002 @default.
• W3186486251 hasConceptScore W3186486251C134018914 @default.
• W3186486251 hasConceptScore W3186486251C159641895 @default.
• W3186486251 hasConceptScore W3186486251C164705383 @default.
• W3186486251 hasConceptScore W3186486251C2778653478 @default.
• W3186486251 hasConceptScore W3186486251C2779464278 @default.
• W3186486251 hasConceptScore W3186486251C2908647359 @default.
• W3186486251 hasConceptScore W3186486251C45393284 @default.
• W3186486251 hasConceptScore W3186486251C500558357 @default.
• W3186486251 hasConceptScore W3186486251C555293320 @default.
• W3186486251 hasConceptScore W3186486251C71924100 @default.
• W3186486251 hasConceptScore W3186486251C99454951 @default.
• W3186486251 hasLocation W31864862511 @default.
• W3186486251 hasLocation W31864862512 @default.
• W3186486251 hasOpenAccess W3186486251 @default.

• next